Company’s plan to stop selling long-acting opioid substitution treatment in Australia ‘a disaster’ July 1, 2026
FDA accused of demanding 10-hour placebo brain surgeries to approve Huntington’s disease therapy March 12, 2026
We are losing treatment options: Why doctors need to fight back against the never-ending drug shortages October 23, 2024
Tobacco giant Philip Morris sells its prescription inhaler business after doctor backlash September 19, 2024
Are pharma-funded awareness campaigns a blind spot in prescription advertising rules? August 10, 2023